About Yapanbio
Yapanbio is a company based in Hyderabad (India) founded in 2019 by Nirav Desai and Atin Tomar.. Yapanbio has raised $13.4 million across 1 funding round from investors including Piramal Group and Piramal Pharma Solutions. The company has 49 employees as of April 06, 2024. Yapanbio offers products and services including Process Development, Process Characterization, and GMP Manufacturing. Yapanbio operates in a competitive market with competitors including Neovacs, Intravacc, Fina Biosolutions, VERAXA and Primrose Bio, among others.
- Headquarter Hyderabad, India
- Employees 49 as on 06 Apr, 2024
- Founders Nirav Desai, Atin Tomar
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Yapan Bio Private Limited
- Date of Incorporation 11 Oct, 2019
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$1.97 M (USD)-30.79as on Mar 31, 2023
-
Net Profit
$18.16 K (USD)-98.49as on Mar 31, 2023
-
EBITDA
$728.37 K (USD)-66.62as on Mar 31, 2023
-
Total Equity Funding
$13.4 M (USD)
in 1 rounds
-
Latest Funding Round
$13.4 M (USD), Series B
Dec 21, 2021
-
Investors
Piramal Group
& 1 more
-
Employee Count
49
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Yapanbio
Yapanbio offers a comprehensive portfolio of products and services, including Process Development, Process Characterization, and GMP Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Optimization and scale-up for manufacturing processes.
Establishment of models for process parameters.
Production of vaccines and biologics for studies.
Unlock access to complete
Funding Insights of Yapanbio
Yapanbio has successfully raised a total of $13.4M through 1 strategic funding round. The most recent funding activity was a Series B round of $13.4 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $13.4M
-
First Round
First Round
(21 Dec 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Series B - Yapanbio | Valuation | Piramal Pharma Solutions , Piramal Group |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Yapanbio
Yapanbio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Piramal Group and Piramal Pharma Solutions. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Serves as a contract manufacturer of pharmaceutical products for industry partners.
|
Founded Year | Domain | Location | |
|
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Yapanbio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Yapanbio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Yapanbio Comparisons
Competitors of Yapanbio
Yapanbio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neovacs, Intravacc, Fina Biosolutions, VERAXA and Primrose Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccine manufacturing services are provided by Neovacs CDMO.
|
|
| domain | founded_year | HQ Location |
Vaccine development services for bacterial and viral vaccines are provided.
|
|
| domain | founded_year | HQ Location |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| domain | founded_year | HQ Location |
Antibody therapeutics for cancer treatment are developed via microfluidic screening.
|
|
| domain | founded_year | HQ Location |
New molecules are discovered, developed, and manufactured in biotechnology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Yapanbio
When was Yapanbio founded?
Yapanbio was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Where is Yapanbio located?
Yapanbio is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Who is the current CEO of Yapanbio?
Atin Tomar is the current CEO of Yapanbio. They have also founded this company.
Is Yapanbio a funded company?
Yapanbio is a funded company, having raised a total of $13.4M across 1 funding round to date. The company's 1st funding round was a Series B of $13.4M, raised on Dec 21, 2021.
How many employees does Yapanbio have?
As of Apr 06, 2024, the latest employee count at Yapanbio is 49.
What is the annual revenue of Yapanbio?
Annual revenue of Yapanbio is $1.97M as on Mar 31, 2023.
What does Yapanbio do?
Yapanbio was founded in 2019 and is based in Hyderabad, India. Operations focus on the biotechnology sector, where contract manufacturing services for bio-therapeutics and vaccines are delivered. Expertise is applied in production processes to support pharmaceutical needs. Leadership includes co-founders Nirav Desai and Atin Tomar, who oversee strategic and executive functions. The company serves clients through specialized facilities in the region.
Who are the top competitors of Yapanbio?
Yapanbio's top competitors include Neovacs, VERAXA and Fina Biosolutions.
What products or services does Yapanbio offer?
Yapanbio offers Process Development, Process Characterization, and GMP Manufacturing.
Who are Yapanbio's investors?
Yapanbio has 2 investors. Key investors include Piramal Group, and Piramal Pharma Solutions.